Press Release FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data at the Society for Neuro-Oncology 2023 Annual Meeting 10 November 2023
Press Release JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA 10 November 2023
Press Release Global Foot Care Products Strategic Analysis Report 2023: Market to Reach $4.4 Billion by 2030 from $2.9 Billion in 2022 – Manufacturers Focus on Enabling Self-Care, Educating Customers – ResearchAndMarkets.com 10 November 2023
Press Release FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma 10 November 2023
Press Release Electra Provides Notice of Third Quarter 2023 Results Conference Call and Webcast 10 November 2023
Press Release Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting 10 November 2023
